Earnings Summary

Vaxcyte Inc’s net profit fell -55.09% since last year same period to $-60.46Mn in the Q1 2023. On a quarterly growth basis, Vaxcyte Inc has generated 22.53% jump in its net profits since last 3-months.

Vaxcyte Inc’s earning per share (EPS) estimates for the current quarter stand at -0.82 - a 2.38% jump from last quarter’s estimates.

Vaxcyte Inc’s earning per share (EPS) estimates for the current year stand at -0.82.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Vaxcyte Inc’s return on assets (ROA) stands at -0.23.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Vaxcyte Inc’s return on equity (ROE) stands at -0.38.